https://insights.citeline.com/hbw-insight/beauty/innovationandip/new-products/paris-in-cosmetics-global-2026-ingredient-preview-VQQ2WPSWVVFA3IMDWK5MZV2K4E/2026-04-08T22:59:56.241Zalways0.5https://insights.citeline.com/resizer/T4bXpr_0d-V8nttRJADuNlfBZKI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2HCQAD27DNG7FC5IVNFAYKL5RQ.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/compliance/no-standard-conference-aami-nexus-looks-to-whats-next-in-medtech-regulation-HVKVDMPW35A2DE3M3W4S4VC46A/2026-04-08T21:54:18.847Zalways0.5https://insights.citeline.com/resizer/m_kpFWVh_MZz0Bk3LmtC63_YhlA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QWKADNM2BZFV3CMTMEFVVCIKWI.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/us-fda/fda-and-industry-reach-agreement-in-principle-on-mdufa-vi-framework-SBLT2OS7TFEWZCIV6YCAEZ4QBY/2026-04-08T19:57:21.264Zalways0.5https://insights.citeline.com/resizer/fIkWSqCoAb2wsKIJMlZTPRRb4_0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IFBWPNSKEBA7BCOW2OUIQY5N6Y.jpghttps://insights.citeline.com/medtech-insight/business/r-and-d/clinical-trials/dexcoms-ceo-jake-leach-discusses-new-trial-data-focus-to-enhance-user-experience-stelo-upgrade-QS2IR3KRANAVBLJAID77AYYJI4/2026-04-08T19:40:47.492Zalways0.5https://insights.citeline.com/resizer/Ghu2qUMqwtxgEPD4dpvBtCEqjsw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JNMHUMATWJFNFOUSFFYAJB7NKE.jpghttps://insights.citeline.com/medtech-insight/device-area/cardiology/no-new-hardware-required-bds-hemosphere-stream-to-bring-continuous-bp-monitoring-to-any-bedside-QONU3XSYWRGF7GVU6YGS2T43KE/2026-04-08T18:10:11.43Zalways0.5https://insights.citeline.com/resizer/hTBMQXiwv1b3e4a6BtTBpNQWjZ4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XT4J3MHU5FBJPIBJLOCAN4YXLM.jpghttps://insights.citeline.com/hbw-insight/health/innovationandip/new-products/prestige-launches-hayfever-eye-drops-in-the-uk-ESF33HGK7ZFJNA53AS3JT4ACQ4/2026-04-08T16:33:30.545Zalways0.5https://insights.citeline.com/resizer/Qr6ZFcOv_HmhQVTOIwuKzinLp4I=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FUSUXUZPA5LNZCTW3F2MRH63MU.jpghttps://insights.citeline.com/medtech-insight/business/financing/route-92-medical-raises-50m-to-grow-stroke-intervention-business-7R54XQFYBVHRNOYXY576EOVFMU/2026-04-08T16:10:19.407Zalways0.5https://insights.citeline.com/resizer/-qTW-GTvvHbra3fSzG6rix8XESI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/S2I7GFNHCZIQLIYHJIPNGQ6EM4.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/regulation/eu-notified-bodies-say-mdrivdr-proposals-would-carry-increased-risk-to-public-health-ZGLLXJ5JPJABPNTBPWO5RO3YBE/2026-04-08T16:03:08.489Zalways0.5https://insights.citeline.com/resizer/2MCMNgx42QAfk13QZXCvnASdK6U=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HB5O5EKPV5PRBHIIVSJNKNZTPY.jpghttps://insights.citeline.com/hbw-insight/health/business/deals/prestige-consumer-healthcare-takes-deep-international-breath-with-breathe-right-deal-X25QQC4DDZBCDFI2WFEI4UW7BQ/2026-04-08T15:32:29.807Zalways0.5https://insights.citeline.com/resizer/mndEpImpHSOZCwhJ-A3E9bNemU4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YIOK2EZT5FESLI45P72HPRGL5M.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/user-fees/us-fdas-fy-2027-budget-proposes-non-user-fee-funding-cuts-adds-fee-protection-dollars-XNOHGCCKAFG5VCWZFMSGI6NRIY/2026-04-08T14:55:08.596Zalways0.5https://insights.citeline.com/resizer/NgpERL5NyUq9GQgouweJ1L4S2Cg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GXY2IJ5AUBECXK7IUNAR5WU7ME.jpghttps://insights.citeline.com/scrip/focus-on-asia/india/indias-high-stakes-oral-semaglutide-battle-and-novos-snac-test-LEFTFIZEHNCM7DD6MDWKN4K6DA/2026-04-08T13:42:18.053Zalways0.5https://insights.citeline.com/resizer/eXu1n3T62hA61t5uZgu8c9RqDSI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NYCXZVDEKJCHTPPTE56EBLNN6A.jpghttps://insights.citeline.com/pink-sheet/biosimilars-and-generics/generics/hatch-waxman-repairs-could-help-fight-serial-patent-litigations-SCZAB2SCKJG3FHRJNPVPRJYTTI/2026-04-08T13:28:30.815Zalways0.5https://insights.citeline.com/resizer/wzdPy2ETYn-NqqEPUBADBmpRiPw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TE3XOEWQ3JBD5LBYC35VVFZBNA.jpeghttps://insights.citeline.com/pink-sheet/product-reviews/approvals/grifols-fesilty-review-shows-us-fda-still-can-deliver-timely-approvals-HYIINPIQPJFKVCKI6J5JVMRLGU/2026-04-08T11:50:15.402Zalways0.5https://insights.citeline.com/resizer/bm7ZrPHHPfOmlTWep0HVtmOuA-o=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WWG6P74Y2VF2VKUNNP776CVDGU.jpghttps://insights.citeline.com/generics-bulletin/business/deals/lotus-to-take-over-sandozs-portfolio-in-the-philippines-PLEY6DVIOFA5ZCVXBLJX76XTDQ/2026-04-08T10:48:25.942Zalways0.5https://insights.citeline.com/resizer/6Uu6C1EHRCxw63o8W0fH1x4zuZA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DJRV7HX365BMHOHHS2SQQIQJ5M.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/apotex-moves-into-denosumab-as-canadian-competition-accelerates-I3S7XQ66KJHTLMSHW2N5OAQPMQ/2026-04-08T10:30:54.684Zalways0.5https://insights.citeline.com/resizer/txwEj53_GwK4vR81rKrtvsevWtg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RCXKVGWL6ZJCLAXZI2LQMFULGQ.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/aeon-finances-creak-as-biosimilar-momentum-builds-W7D5VDKDAJF4DJXZVNCOMUUFD4/2026-04-08T10:30:47.069Zalways0.5https://insights.citeline.com/resizer/SGqL4ri4n20zPldDvYzSh0Y3CJo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SPFOQWXWMZAQ3LD6SIE54PYZ7M.jpghttps://insights.citeline.com/generics-bulletin/products/generics/us-opens-farxiga-to-generics-after-pricing-overhaul-65ZXHKBFTVEYLFDKF2JQE2YTPA/2026-04-08T10:30:45.571Zalways0.5https://insights.citeline.com/resizer/o47fPuullaDmKDRnGaA1LvYOFhE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3PEEDOJFCBNIPB2N72UWAGDM5I.jpghttps://insights.citeline.com/scrip/business/deals/licensing-deal-for-progeria-drug-could-benefit-zydus-in-more-ways-than-one-KJAJUVK5KNBHTFKMVJNEDPF5OY/2026-04-08T08:43:29.599Zalways0.5https://insights.citeline.com/resizer/4hXgMZpSyo9Pz88P9ognMddxeM4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UMT2HXEMVZF4BD55AOE2RE6WUE.jpghttps://insights.citeline.com/in-vivo/growth/glp-1s-were-just-the-start-the-next-wave-of-obesity-therapies-D2O673SCBNCXXB2PVQCPWMATVY/2026-04-08T07:53:35.481Zalways0.5https://insights.citeline.com/resizer/CTXT8yj4D19H8uyh7owSUopnGtk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/S6CMVHYDDBDIFDH73VFHBBBQ3Y.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/sanofis-lunsekimig-delivers-in-respiratory-phase-ii-studies-misses-in-dermatitis-JYPCI34TXRFS7JW3YZPN7OML4Y/2026-04-08T00:20:58.999Zalways0.5https://insights.citeline.com/resizer/Zw7Xot3-Ww6eJe_Ewp5EST-IPhQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3LYX5KERPRFZNHJVSZKO7Q7JUE.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/praxis-adds-to-neuroscience-momentum-with-epilepsy-trial-success-AZ2QSR24MZBFZKQTWOIXOUJB5E/2026-04-08T00:20:27.514Zalways0.5https://insights.citeline.com/resizer/VwC5X2gVJibnESVPSXtpK8mc0Rg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/U3PVGNMA3JGI5IEH64R4IPFHTQ.jpghttps://insights.citeline.com/scrip/business/stock-watch/stock-watch-war-what-is-it-good-for-FVFT5SYRRFE6NFLGBATTA2S5PY/2026-04-08T00:19:52.684Zalways0.5https://insights.citeline.com/resizer/YIL2M1ae62y1e92FsV3bmfgLaHo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/K56F2ZRYMVIAHKNZC7TX5XL7H4.jpghttps://insights.citeline.com/scrip/business/deals/deal-watch/deal-watch-ma-pace-accelerated-in-march-with-continued-robust-activity-in-april-S24JR3XUPFEWDBINPVY2S6L4DY/2026-04-08T00:19:38.824Zalways0.5https://insights.citeline.com/resizer/rZ6sS5sBWUbSiS7khxRBa3DxUs8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZW4NDNZLVRNYPCAOCELQGOJS7I.jpghttps://insights.citeline.com/scrip/business/deals/gileads-2026-shopping-spree-continues-with-tubulis-buyout-YU5GFZBIMNF5HP4P2FFJPS2J6A/2026-04-08T00:19:33.39Zalways0.5https://insights.citeline.com/resizer/YbC2YKZyINU75xFQhqCmr0RmUKs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XOCVJ5DTBNFBNHOF4NYFROFPOU.jpghttps://insights.citeline.com/companies/recurv-pharma2026-04-08T00:10:12.477Zalways0.5https://insights.citeline.com/companies/stipple-bio-inc2026-04-08T00:10:07.828Zalways0.5https://insights.citeline.com/companies/guangdong-qiangji-pharmaceutical-co-ltd2026-04-08T00:09:57.392Zalways0.5https://insights.citeline.com/companies/beijing-synthetic-vaccine-biosciences-co-ltd2026-04-08T00:09:48.196Zalways0.5https://insights.citeline.com/companies/mastelli-srl2026-04-08T00:09:42.292Zalways0.5https://insights.citeline.com/companies/biosyn-beijing-biotechnology-co-ltd2026-04-08T00:09:38.185Zalways0.5https://insights.citeline.com/companies/c2x-pharma2026-04-08T00:09:34.152Zalways0.5https://insights.citeline.com/companies/emma-health2026-04-08T00:09:30.312Zalways0.5https://insights.citeline.com/companies/xian-qinshen-jiahe-pharmaceutical-research-co-ltd2026-04-08T00:09:26.33Zalways0.5https://insights.citeline.com/companies/carrier-biomed-suzhou-biomedical-co-ltd2026-04-08T00:09:14.3Zalways0.5https://insights.citeline.com/companies/yoda-pharmaceuticals-inc2026-04-08T00:09:10.304Zalways0.5https://insights.citeline.com/companies/jabez-biosciences-inc2026-04-08T00:09:06.113Zalways0.5https://insights.citeline.com/companies/liquet-medical-inc2026-04-08T00:09:02.112Zalways0.5https://insights.citeline.com/companies/prolium-bioscience2026-04-08T00:08:58.221Zalways0.5https://insights.citeline.com/companies/livekidneybio2026-04-08T00:08:54.118Zalways0.5https://insights.citeline.com/companies/neurobiogen2026-04-08T00:08:49.909Zalways0.5https://insights.citeline.com/companies/adaptin-bio-inc2026-04-08T00:08:46.004Zalways0.5https://insights.citeline.com/companies/mabpharm2026-04-08T00:08:37.8Zalways0.5https://insights.citeline.com/companies/himuka-am-pharma2026-04-08T00:08:33.631Zalways0.5https://insights.citeline.com/companies/jiangsuyayo-biotech2026-04-08T00:08:28.831Zalways0.5https://insights.citeline.com/companies/xylo-bio2026-04-08T00:08:23.119Zalways0.5https://insights.citeline.com/companies/octavian-therapeutics2026-04-08T00:08:16.782Zalways0.5https://insights.citeline.com/companies/crohns-colitis-foundation2026-04-08T00:08:10.95Zalways0.5https://insights.citeline.com/companies/gleamer2026-04-08T00:08:04.681Zalways0.5https://insights.citeline.com/companies/corstasis-therapeutics-inc2026-04-08T00:07:58.682Zalways0.5https://insights.citeline.com/companies/nimmune-biopharma-inc2026-04-08T00:07:52.649Zalways0.5https://insights.citeline.com/companies/university-of-pittsburgh-medical-center-upmc2026-04-08T00:07:46.782Zalways0.5https://insights.citeline.com/companies/generate-biomedicines-inc2026-04-08T00:07:40.491Zalways0.5https://insights.citeline.com/companies/novalgen-ltd2026-04-08T00:07:34.511Zalways0.5https://insights.citeline.com/companies/front-line-medical-technologies-inc2026-04-08T00:07:22.541Zalways0.5https://insights.citeline.com/companies/centessa-pharmaceuticals-plc2026-04-08T00:07:16.631Zalways0.5https://insights.citeline.com/companies/janux-therapeutics2026-04-08T00:07:10.52Zalways0.5https://insights.citeline.com/companies/alloy-therapeutics-inc2026-04-08T00:07:04.441Zalways0.5https://insights.citeline.com/companies/apnimed-inc2026-04-08T00:06:58.373Zalways0.5https://insights.citeline.com/companies/liqmeds-worldwide-limited2026-04-08T00:06:52.713Zalways0.5https://insights.citeline.com/companies/movano-inc2026-04-08T00:06:40.49Zalways0.5https://insights.citeline.com/companies/tubulis-gmbh2026-04-08T00:06:34.595Zalways0.5https://insights.citeline.com/companies/keros-therapeutics2026-04-08T00:06:28.179Zalways0.5https://insights.citeline.com/companies/biotech-pharma-co-ltd2026-04-08T00:06:22.218Zalways0.5https://insights.citeline.com/companies/vaccgen-international-llc2026-04-08T00:06:16.319Zalways0.5https://insights.citeline.com/companies/oxford-nanopore-technologies-plc2026-04-08T00:06:10.134Zalways0.5https://insights.citeline.com/companies/youcare-pharmaceutical-group-co-ltd2026-04-08T00:06:04.238Zalways0.5https://insights.citeline.com/companies/select-therapeutics-inc2026-04-08T00:05:58.278Zalways0.5https://insights.citeline.com/companies/essilorluxottica2026-04-08T00:05:51.892Zalways0.5https://insights.citeline.com/companies/jsr-corp2026-04-08T00:05:46.061Zalways0.5https://insights.citeline.com/companies/targeted-diagnostics-therapeutics-inc2026-04-08T00:05:39.956Zalways0.5https://insights.citeline.com/companies/yeshiva-university2026-04-08T00:05:34.028Zalways0.5https://insights.citeline.com/companies/concentrx-pharmaceuticals-inc2026-04-08T00:05:27.875Zalways0.5https://insights.citeline.com/companies/jasper-therapeutics-inc2026-04-08T00:05:15.798Zalways0.5https://insights.citeline.com/companies/xeno-biosciences-inc2026-04-08T00:05:09.804Zalways0.5https://insights.citeline.com/companies/foundation-fighting-blindness2026-04-08T00:05:03.829Zalways0.5https://insights.citeline.com/companies/neximmune-inc2026-04-08T00:04:57.578Zalways0.5https://insights.citeline.com/companies/cristcot-llc2026-04-08T00:04:51.609Zalways0.5https://insights.citeline.com/companies/kings-college-london2026-04-08T00:04:45.586Zalways0.5https://insights.citeline.com/companies/episurf-medical-ab2026-04-08T00:04:39.551Zalways0.5https://insights.citeline.com/companies/noile-immune-biotech-inc2026-04-08T00:04:33.412Zalways0.5https://insights.citeline.com/companies/neurosync-inc2026-04-08T00:04:21.382Zalways0.5https://insights.citeline.com/companies/nextcell-pharma-ab2026-04-08T00:04:15.85Zalways0.5https://insights.citeline.com/companies/brainstorm-cell-therapeutics-inc2026-04-08T00:04:09.307Zalways0.5https://insights.citeline.com/companies/esperion-therapeutics-inc2026-04-08T00:04:03.36Zalways0.5https://insights.citeline.com/companies/jupiter-neurosciences-inc2026-04-08T00:03:42.282Zalways0.5https://insights.citeline.com/companies/kezar-life-sciences-inc2026-04-08T00:03:30.382Zalways0.5https://insights.citeline.com/companies/karl-storz-gmbh-co-kg2026-04-08T00:03:18.188Zalways0.5https://insights.citeline.com/companies/soleno-therapeutics-inc2026-04-08T00:03:06.104Zalways0.5https://insights.citeline.com/companies/kaneka-corporation2026-04-08T00:02:42.044Zalways0.5https://insights.citeline.com/companies/kalvista-pharmaceuticals-inc2026-04-08T00:02:30.278Zalways0.5https://insights.citeline.com/companies/genentech-inc2026-04-08T00:02:18.351Zalways0.5https://insights.citeline.com/companies/vivoryon-therapeutics-nv2026-04-08T00:02:06.128Zalways0.5https://insights.citeline.com/companies/eli-lilly-and-company2026-04-08T00:01:54.037Zalways0.5https://insights.citeline.com/companies/boston-scientific-corporation2026-04-08T00:01:42.121Zalways0.5https://insights.citeline.com/companies/hologic-inc2026-04-08T00:01:29.995Zalways0.5https://insights.citeline.com/companies/windtree-therapeutics-inc2026-04-08T00:01:06.25Zalways0.5